Ph.D. David BROWN Chief Executive Officer, Cellzome AG
CV
| Since September 2002 President and CEO of Cellzome, an emerging Biopharmaceutical company based in Cambridge, UK, and Heidelberg, Germany | |
| At Cellzome, Dr. Brown has focused the company's proteomics platform to create drugs to treat Alzheimer's disease, diabetes, and inflammatory diseases. | |
| Dr Brown 28 years experience in major Pharma and has served with 4 of the top 10 Pharma companies: Roche, Glaxo, Pfizer and Zeneca. | |
| Global Head of Drug Discovery, Roche Pharma, Basel, Switzerland, where he had responsibility for the output of clinical candidate drugs from approximately 2000 scientists across Roche's 5 research sites. | |
| Extensive experience of pharmaceutical R&D in all phases from early discovery through clinical trials. | |
| Experience of leading research in all major disease areas. | |
| Whilst at Pfizer he was named co-inventor on the patent for Viagra and he led the team that developed Viagra through to proof of concept (clinical efficacy) in man. | |
| At Roche, in addition to his role in leading Discovery, Dr Brown also served on the committee responsible for clinical drug development and he was a core member of the business development committee responsible for in-licensing of products and for technology agreements and acquisitions. |
